Pengfei Liu, Ph.D.
Picture

Pengfei Liu, Ph.D.
Director
Positions
- Director
-
ACGME/ABMGG Laboratory Genetics and Genomics Fellowship Program
²ÝÁñÉçÇøÈë¿Ú
Houston, Texas United States
- Associate Clinical Director
-
NGS/Molecular
Baylor Genetics
- Associate Professor
-
Molecular and Human Genetics
²ÝÁñÉçÇøÈë¿Ú
- Director
-
Medical Genetics and Multiomics Laboratory (MGML)
Education
- PhD from ²ÝÁñÉçÇøÈë¿Ú
- 01/2012 - Houston, TX
Certifications
- Clinical Molecular Genetics
- #2015130
- American Board of Medical Genetics and Genomics
- Laboratory Genetics and Genomics
- #2023143
- merican Board of Medical Genetics and Genomics
Honors & Awards
- C. W. Cotterman Award
- The American Society of Human Genetics (01/2012)
- The 10 most significant advances in genomic medicine for 2019, by NHGRI
- https://www.cell.com/ajhg/pdf/S0002-9297(19)30427-6.pdf
- Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award
- The ACMG Foundation for Genetic and Genomic Medicine (03/2022)
Professional Interests
- Clinical whole genome sequencing
- Medical genetics
- Genomic disorders
Professional Statement
Dr. Liu is a board-certified PhD clinical geneticist with a primary research interest in translating new technologies into clinical testing to advance the diagnostics and therapy of rare diseases. His clinical work has provided key evidence to recognize the necessity and importance of clinical reanalysis of diagnostic exome data. Dr. Liu has led the launch of clinical whole genome sequencing at Baylor Genetics as well as the clinical RNA-seq for the Undiagnosed Diseases Network (UDN). He has received multiple honors and awards, including the Michael Watson’s Genome Medicine Innovation Award from the ACMG, the Genomic Innovator Award from the NHGRI, and the Cotterman Award from the ASHG.Websites
Selected Publications
- Yuan B, Neira J, Pehlivan D, [...], Xiao R, Liu, P. "." Genet Med. 2018; Pubmed PMID:
- Liu P, Yuan B, Carvalho CM, [...], Hurles ME, Lupski JR. "." Cell. 2017;168:830. Pubmed PMID:
- Liu P, Erez A, Nagamani SC, [...], Lupski JR, Bi W. "." Cell. 2011;146:889. Pubmed PMID:
- Liu P, Meng L, Normand EA, [...], Lupski JR, Yang Y. "." N Engl J Med. 2019;380:2478. Pubmed PMID:
- Vetrini F, McKee S, Rosenfeld JA, [...], Lupski JR, Liu P. "." Genome Med. 2019;11:12. Pubmed PMID:
- Mao D, Liu C, Wang L, (…), Liu P, Liu Z. "." NEJM AI. 2024;1:10.1056/aioa2300009. Pubmed PMID:
- Zhao S, Macakova K, Sinson J, (…), Liu P. "Clinical validation of RNA sequencing for Mendelian disorder diagnostics." medRxiv. 2024;doi.org/10.1101/2024.08.15.24312057
- Yuan, B, Schulze, K, (...), Liu P "Sequencing individual genomes with recurrent deletions reveals allelic architecture and disease loci for autosomal recessive traits.." Genome Med. 2022;14:113.
- Li S, Zhao S, Sinson JC, (…), Liu P. "." Am J Hum Genet. 2024;111:841-862. Pubmed PMID:
- Du H, Jolly A, Grochowski CM, (…), Liu P. "." Genome Med. 2022;14:122. Pubmed PMID:
Funding
- Characterizing disease-causing variants using personal genomes with large recurrent deletions - #R35 HG011311 (07/01/2021 - 06/30/2026) NHGRI
- PI: Pengfei Liu
- Clinical Sequencing Core Facility for the Undiagnosed Diseases Network (UDN) - #U01 HG007942 (09/22/2014 - 06/30/2022) NHGRI
- PI: Christine Eng
to edit your profile